Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1188308010 | Co-flumactone 50mg/50mg tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2572042015 | Hydroflumethiazide + spironolactone 50mg/50mg tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2576028013 | Hydroflumethiazide + spironolactone 50mg/50mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3483343013 | Product containing hydroflumethiazide 50 mg and spironolactone 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3491213018 | Product containing hydroflumethiazide 50 mg and spironolactone 50 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3500166013 | Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3565163011 | Product containing only hydroflumethiazide 50 mg and spironolactone 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3565164017 | Product containing only hydroflumethiazide 50 mg and spironolactone 50 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3679624011 | Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3679625012 | Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 462170019 | Co-flumactone 50mg/50mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 714547012 | Co-flumactone 50mg/50mg tablet (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide and spironolactone only product in oral dose form | true | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide- and spironolactone-containing product | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Spironolactone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has BoSS | Spironolactone | true | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has BoSS | Hydroflumethiazide | true | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has precise active ingredient | Hydroflumethiazide | true | Inferred relationship | Some | 2 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has precise active ingredient | Spironolactone | true | Inferred relationship | Some | 1 | |
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide- and spironolactone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR